Breast Elasticity Imaging During Neoadjuvant Chemotherapy

Description

For this study, the investigators propose investigation of a new imaging technique, Harmonic Motion Imaging (HMI), and the evaluation of its potential role in prediction of breast cancer response to neoadjuvant chemotherapy (NACT). The investigators hypothesize that changes in HMI parameters will predict response to neoadjuvant systemic therapy in early-stage breast cancer.

Conditions

Breast Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

For this study, the investigators propose investigation of a new imaging technique, Harmonic Motion Imaging (HMI), and the evaluation of its potential role in prediction of breast cancer response to neoadjuvant chemotherapy (NACT). The investigators hypothesize that changes in HMI parameters will predict response to neoadjuvant systemic therapy in early-stage breast cancer.

Predicting Response to Neoadjuvant Chemotherapy Using Harmonic Motion Imaging in Women With Breast Cancer

Breast Elasticity Imaging During Neoadjuvant Chemotherapy

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

New York

Columbia University Irving Medical Center/NYP, New York, New York, United States, 10032

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Women age ≥18
  • * Deemed eligible to receive neoadjuvant systemic therapy as per the treating physician, with the dose and schedule deemed appropriate by the treating physician.
  • * Any stage invasive breast cancer provided the primary breast tumor size is ≥ 4 mm
  • * Patient is pregnant or lactating
  • * Presence of breast implants
  • * History of laser or radiation therapy to the affected breast

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Columbia University,

Elisa Konofagou, PhD, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

2026-05